How many institutional investors hold SMMT?

4 tracked institutional investors disclosed a position in SMMT (SUMMIT THERAPEUTICS INC) in their most recent 13F filing.

Who is the largest institutional holder of SMMT?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in SMMT, valued at $56M.

Did institutional ownership of SMMT increase or decrease?

Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited SMMT.

Where does this SMMT ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

SMMT — SUMMIT THERAPEUTICS INC

Name: SUMMIT THERAPEUTICS INC (SMMT) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About SUMMIT THERAPEUTICS INC (SMMT)

SUMMIT THERAPEUTICS INC (SMMT) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $56M. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in SMMT

/100

Mixed Activity

Added / Increased0

Reduced0

Exited0

No recent activity recorded.

Crowded Trade Score™

How many top investors track SMMT

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

SMMT Ownership Composition

How SUMMIT THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

66% of tracked value

Institutions

tracked investors

Total Reported

$45.2M

combined 13F value

Other66.4%
Hedge Funds33.6%

Other(3)

66.4%

Hedge Funds(1)

33.6%

Tracked investors reporting SMMT

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	1.1M	$20.1M	0.00%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	801.1K	$15.2M	0.02%	Mar 31, 2026
Izzy Englander	Millennium Management	126.3K	$2.4M	0.00%	Mar 31, 2026
Paul Tudor Jones	Tudor Investment Corp	395.1K	$7.5M	0.01%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
1.1M
Value
$20.1M
% Portfolio
0.00%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
801.1K
Value
$15.2M
% Portfolio
0.02%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
126.3K
Value
$2.4M
% Portfolio
0.00%
Paul Tudor JonesMar 31, 2026
Tudor Investment Corp
Shares
395.1K
Value
$7.5M
% Portfolio
0.01%

Recent activity

Investor	Action	Δ %	Current value	Filing date
No recent activity.

No recent activity.

Frequently asked questions

How many institutional investors hold SMMT?: 4 tracked institutional investors disclosed a position in SMMT (SUMMIT THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of SMMT?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in SMMT, valued at $56M.
Did institutional ownership of SMMT increase or decrease?: Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited SMMT.
Where does this SMMT ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.